MARKET

VCYT

VCYT

Veracyte
NASDAQ
24.63
-0.48
-1.91%
After Hours: 24.39 -0.24 -0.97% 19:54 11/12 EST
OPEN
24.60
PREV CLOSE
25.11
HIGH
25.30
LOW
24.07
VOLUME
2.51M
TURNOVER
--
52 WEEK HIGH
60.91
52 WEEK LOW
21.91
MARKET CAP
1.99B
P/E (TTM)
15.96
1D
5D
1M
3M
1Y
5Y
1D
Veracyte (VCYT) Securities Investigation Notice - Levi & Korsinsky
PR Newswire · 11h ago
Veracyte: Solid Profits, Slowing Tests, And A Stock In Limbo
Seeking Alpha · 11h ago
Veracyte Is Maintained at Overweight by Stephens & Co.
Dow Jones · 1d ago
Veracyte Price Target Cut to $40.00/Share From $55.00 by Stephens & Co.
Dow Jones · 1d ago
Stephens & Co. Maintains Overweight on Veracyte, Lowers Price Target to $40
Benzinga · 1d ago
Veracyte price target lowered to $40 from $55 at Stephens
TipRanks · 1d ago
Veracyte price target lowered to $40 from $66 at Freedom Capital
TipRanks · 2d ago
Veracyte Is Maintained at Overweight by Piper Sandler
Dow Jones · 2d ago
More
About VCYT
Veracyte, Inc. is a global diagnostics company. The Veracyte Diagnostics Platform delivers cancer tests that are fueled by broad genomic and clinical data, deep bioinformatic and AI capabilities, and an evidence-generation engine, which drives durable reimbursement and guideline inclusion for its tests. The Company offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna) and bladder cancer (Decipher Bladder and TrueMRD for MIBC). It has developed the noninvasive Percepta Nasal Swab test to help physicians determine lung cancer risk. All of its tests are serviced through its own Clinical Laboratory Improvement Amendments (CLIA) certified laboratories in South San Francisco, California, San Diego, California and Austin, Texas. The Company has acquired the UroAmp platform, which has been clinically validated in non-muscle invasive bladder cancer (NMIBC), including therapy-response monitoring and post-treatment surveillance.

Webull offers Veracyte Inc stock information, including NASDAQ: VCYT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VCYT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VCYT stock methods without spending real money on the virtual paper trading platform.